Marie-claude C. Massuard-Viaud
Tours, 37032, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Delivery of Anticancer Drugs Using Microbubble-Assisted Ultrasound in a 3D Spheroid Model.
Journal: Molecular pharmaceutics
Published: January 04, 2024
Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases).
Journal: Biochemical pharmacology
Published: November 09, 2023
Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.
Journal: Antibodies (Basel, Switzerland)
Published: June 27, 2022
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer.
Journal: Bioconjugate chemistry
Published: February 01, 2022
Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology.
Journal: Cancers
Published: January 04, 2022
Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.
Journal: European journal of medicinal chemistry
Published: October 20, 2021
Adcitmer® , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.
Journal: The British journal of dermatology
Published: August 28, 2021
Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor.
Journal: International journal of molecular sciences
Published: August 07, 2021
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model.
Journal: Bioconjugate chemistry
Published: February 25, 2021
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: January 07, 2021
Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.
Journal: Archiv der Pharmazie
Published: December 01, 2020
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential.
Journal: ChemMedChem
Published: October 16, 2020
Last Updated: 09/26/2026